Copaxone in Age Related Macular Degeneration

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

April 30, 2007

Conditions
Macular Degeneration
Interventions
DRUG

Copaxone (Glatiramer acetate)

Trial Locations (1)

76100

RECRUITING

Department of Ophthalmology, Kaplan Medical Center, Rehovot

Sponsors
All Listed Sponsors
lead

Kaplan Medical Center

OTHER